HomeCompareHERB vs EQR

HERB vs EQR: Dividend Comparison 2026

HERB yields 12500.00% · EQR yields 4.73%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 HERB wins by $498747976996367872.00M in total portfolio value
10 years
HERB
HERB
● Live price
12500.00%
Share price
$0.02
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$498747976996367872.00M
Annual income
$491,020,681,003,619,800,000,000.00
Full HERB calculator →
EQR
EQR
● Live price
4.73%
Share price
$58.58
Annual div
$2.77
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$40.5K
Annual income
$3,819.61
Full EQR calculator →

Portfolio growth — HERB vs EQR

📍 HERB pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHERBEQR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HERB + EQR cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HERB pays
EQR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HERB
Annual income on $10K today (after 15% tax)
$1,062,500.00/yr
After 10yr DRIP, annual income (after tax)
$417,367,578,853,076,800,000,000.00/yr
EQR
Annual income on $10K today (after 15% tax)
$401.93/yr
After 10yr DRIP, annual income (after tax)
$3,246.67/yr
At 15% tax rate, HERB beats the other by $417,367,578,853,076,800,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HERB + EQR for your $10,000?

HERB: 50%EQR: 50%
100% EQR50/50100% HERB
Portfolio after 10yr
$249373988498183936.00M
Annual income
$245,510,340,501,809,900,000,000.00/yr
Blended yield
98.45%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

HERB
No analyst data
Altman Z
0.8
Piotroski
6/9
EQR
Analyst Ratings
16
Buy
28
Hold
2
Sell
Consensus: Hold
Price Target
$70.35
+20.1% upside vs current
Range: $63.00 — $78.50
Altman Z
1.8
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HERB buys
0
EQR buys
0
No recent congressional trades found for HERB or EQR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHERBEQR
Forward yield12500.00%4.73%
Annual dividend / share$2.00$2.77
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8%
Portfolio after 10y$498747976996367872.00M$40.5K
Annual income after 10y$491,020,681,003,619,800,000,000.00$3,819.61
Total dividends collected$498235517183739840.00M$16.9K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: HERB vs EQR ($10,000, DRIP)

YearHERB PortfolioHERB Income/yrEQR PortfolioEQR Income/yrGap
1← crossover$1,260,700$1,250,000.00$11,248$547.57+$1.25MHERB
2$148,626,986$147,278,037.38$12,701$666.53+$148.61MHERB
3$16,386,101,622$16,227,070,746.70$14,405$814.59+$16386.09MHERB
4$1,689,525,624,319$1,671,992,495,582.84$16,413$999.84+$1689525.61MHERB
5$162,924,168,596,046$161,116,376,178,025.50$18,795$1,232.92+$162924168.58MHERB
6$14,694,663,924,503,782$14,520,335,064,106,012.00$21,639$1,527.95+$14694663924.48MHERB
7$1,239,682,670,110,485,000$1,223,959,379,711,266,000.00$25,057$1,903.80+$1239682670110.46MHERB
8$97,827,968,310,781,350,000$96,501,507,853,763,130,000.00$29,197$2,385.87+$97827968310781.31MHERB
9$7,221,771,955,839,384,000,000$7,117,096,029,746,848,000,000.00$34,250$3,008.70+$7221771955839384.00MHERB
10$498,747,976,996,367,840,000,000$491,020,681,003,619,800,000,000.00$40,467$3,819.61+$498747976996367872.00MHERB

HERB vs EQR: Complete Analysis 2026

HERBStock

YaSheng Group, through its subsidiaries, designs, develops, manufactures, and markets farming and sideline products; chemical materials and products; textiles; construction materials; and livestock and poultry products primarily in the People's Republic of China. It cultivates, processes, markets, and distributes various food and agro-byproducts. The company's products include cotton, corns, barley, wheat, flax, and alfalfa; vegetables comprising onions, potatoes, beet, and peas; fruits, including apples, pears, and apricots; specialty crops consisting of hops, wolfberries, cumin, hemp, and liquorices; seeds, such as black melon, sunflower, corn, hemp, and flax seeds; and eggs. It also provides construction materials, such as cement; and designs, develops, and markets new technologies related to agriculture and genetic biology. The company sells its products to food processors, supermarkets, and wholesale stores through distributors, as well as to direct customers. YaSheng Group exports its products. The company was founded in 1998 and is based in Lanzhou, the People's Republic of China. As of December 31, 2015, YaSheng Group is a subsidiary of Gansu Yasheng Salt Chemical Industrial Group, Ltd.

Full HERB Calculator →

EQRREIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →
📬

Get this HERB vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HERB vs SCHDHERB vs JEPIHERB vs OHERB vs KOHERB vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.